45 results match your criteria: "The Royal College of Pathologists of Australasia[Affiliation]"
Paraprotein Sample Exchange in Australia and New Zealand - 2018.
Clin Biochem Rev
February 2019
Haematology Department, Princess Alexandra Hospital, Brisbane, Qld 4102, Australia.
Quantification of co-migrating paraproteins in the beta-region presents an ongoing challenge for laboratories performing serum protein electrophoresis. The between-laboratory variation may impact patient care if the patient uses different pathology services during plasma cell dyscrasia monitoring. To identify the practical difficulties and determine the extent of agreement in the reporting of beta-migrating paraproteins in Australia and New Zealand (NZ), sample exchanges were conducted in five Australian states and in NZ in early 2018.
View Article and Find Full Text PDFReport of the Survey Conducted by RCPAQAP on Current Practice for Paraprotein and Serum Free Light Chain Measurement and Reporting: a Need for Harmonisation.
Clin Biochem Rev
February 2019
Haematology Department, Princess Alexandra Hospital, Woolloongabba, Qld 4102, Australia.
Clinical laboratory testing is vital in the diagnosis, monitoring and prognostication of monoclonal gammopathies. Although the 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand aimed to harmonise the laboratory practices related to paraprotein testing, the between-laboratory variation still exists. A survey was conducted to assess the between-laboratory variation in certain aspects of laboratory testing related to monoclonal gammopathy.
View Article and Find Full Text PDFCompliance with pathology testing guidelines in Australian general practice: protocol for a secondary analysis of electronic health record data.
BMJ Open
November 2018
South Eastern Melbourne Primary Health Network, Heatherton, Victoria, Australia.
Introduction: In Australia, general practitioners usually are the first point of contact for patients with non-urgent medical conditions. Appropriate and efficient utilisation of pathology tests by general practitioners forms a key part of diagnosis and monitoring. However overutilisationand underutilisation of pathology tests have been reported across several tests and conditions, despite evidence-based guidelines outlining best practice in pathology testing.
View Article and Find Full Text PDFRCPAQAP audit of antimicrobial reporting in Australian and New Zealand laboratories: opportunities for laboratory contribution to antimicrobial stewardship.
J Antimicrob Chemother
January 2019
The Royal College of Pathologists of Australasia Quality Assurance Programs, St Leonards, NSW, Australia.
Objectives: A 2017 laboratory survey conducted by the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) asked participants which antimicrobials they would report for given organisms in either blood or urine cultures in order to identify opportunities for improvement of antimicrobial reporting.
Methods: Over-reporting was defined as reporting of broad-spectrum antimicrobials on isolates susceptible to narrow-spectrum antimicrobials. Inappropriate reporting was defined as reporting antimicrobials not appropriate for the site of infection.
Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy.
J Thromb Thrombolysis
November 2018
Quality Use of Medicines Network, Griffith University, Southport, QLD, Australia.
Warfarin has long been the most widely prescribed oral anticoagulant. Introduction of non-vitamin K oral anticoagulants (NOACs) has provided anticoagulant options but also presented the potential challenge of transitioning between agents. Changes from NOACs to warfarin are particularly problematic with delays to therapeutic effect and limited real-world data regarding the impact on warfarin control.
View Article and Find Full Text PDFConstant Quest for Quality: Digital Cytopathology.
J Pathol Inform
April 2018
The Royal College of Pathologists of Australasia Quality Assurance Programs Pty Ltd, St Leonards, NSW 2065, Australia.
Background: Special consideration should be given when creating and selecting cytopathology specimens for digitization to maximize quality. Advances in scanning and viewing technology can also improve whole-slide imaging (WSI) output quality.
Methods: Accumulated laboratory experience with digitization of glass cytopathology slides was collected.
Finding best practice in internal quality control procedures using external quality assurance performance.
Clin Chem Lab Med
August 2018
The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), St. Leonards, NSW, Australia.
Dedicated warfarin care programme results in superior warfarin control in Queensland, Australia.
Int J Clin Pract
March 2018
Menzies Health Institute and Quality Use of Medicines Network, Griffith University, Queensland, Australia.
Background: Warfarin is used to prevent stroke in patients with atrial fibrillation (AF). Ongoing monitoring of International normalised ratio (INR) and time in therapeutic range (TTR) commonly used to assess the quality of warfarin management are required. Anticoagulant clinics have demonstrated improved TTRs, particularly in countries with poorer control in primary care settings.
View Article and Find Full Text PDFThe Royal College of Pathologists of Australasia Quality Assurance Program: Immunohistochemistry Breast Marker Audit Overview 2005-2015.
Appl Immunohistochem Mol Morphol
January 2019
*Department of Anatomical Pathology, The Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP), Sydney, NSW †Department of Histopathology, Monash Health, Monash Medical Centre, Melbourne, Vic. ‡Department of histopathology, Genomics for Life, Qld, Australia.
The Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP) Anatomical Pathology provides a comprehensive External Quality Assurance (EQA) exercise to review the reporting of immunohistochemistry (IHC) and in-situ hybridization (ISH) breast markers through an audit of clinical results. The aim of this exercise was to provide information regarding the quality of breast marker testing within clinical laboratories from 2005 to 2015. This comprehensive audit included estrogen, progesterone, and HER2 marker reporting.
View Article and Find Full Text PDFThe RCPA Quality Assurance Program in Dermatopathology: A Retrospective Review.
Am J Dermatopathol
March 2018
PathWest Laboratory Medicine.
Aims: To review the Royal College of Pathologists of Australasia (RCPA) Quality Assurance Program Dermatopathology module from 2005 to 2016 to assess diagnostic performance, changes over time, and areas of diagnostic difficulty.
Methods: The computerized records of the RCPA Dermatopathology subspecialist module were reviewed. Cases were categorized into groups including nonneoplastic disorders, neoplasms, and cases with multiple diagnoses.
Compromising the Security of "Generating Unique identifiers from Patient Identification Data Using Security Models".
J Pathol Inform
April 2017
Sydney Medical School, The University of Sydney, NSW 2006, Australia.
Kings to Cowards: One-Punch Assaults.
J Law Med Ethics
June 2016
Jason Schreiber, FFCFM, MFFLM, DipFLM, is a Forensic Physician at the Clinical Forensic Department of the Victorian Institute of Forensic Medicine. Angela Williams, MBBS, GradDipForensMed, MForensMed, GradDipLaw, FFFLM (UK), GAICD, MBA, FFCFM (RCPA), is a Senior Forensic Physician in the Clinical Forensic Medicine Department of the Victorian Institute of Forensic Medicine. She is an Adjunct Senior Lecturer in the Department of Forensic Medicine at Monash University, Victoria, Australia. Dr Williams is a Founding Fellow of the Faculty of Clinical Forensic Medicine of the Royal College of Pathologists of Australasia and a Fellow of the Faculty of Forensic and Legal Medicine of the Royal College of Physicians, United Kingdom. David Ranson, B. Med. Sci., B.M., B.S., LLB., FRCPath., FRCPA., FACLM., FFFLM., FFCFM., DMJ (Path)., is a is Deputy Director of the Victorian Institute of Forensic Medicine in charge of the Forensic Service Division which covers a range of Forensic Laboratory Sciences, Clinical Forensic Medicine and Forensic Pathology.
Methodology: Literature Review and medico-legal commentary.
Results: Fatal one-punch assaults have been reported extensively in the media. This article provides a commentary on recent policy developments and legislative amendments in Australia regarding so called 'one-punch' assaults.
Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Arch Pathol Lab Med
October 2016
From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley).
Context: -The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists-Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world.
Objective: -To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum.
Point-of-care testing: High time for a dedicated National Adverse Event Monitoring System.
Clin Biochem Rev
February 2015
Northland District Health Board.
Recommendations for reporting and flagging of reference limits on pathology reports.
Clin Biochem Rev
November 2014
Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Qld 4029, Australia.
Surveys by the RCPA PITUS Project have shown significant variations in report rendering between Australasian Pathology Providers. The same project collected anecdotal evidence that this variation has led to the misunderstanding and misreading of results - a clinical safety issue. Recommendations are given for the rendering of reference limits on pathology reports, determination and rendering of result flags, and the documentation of sub-population partitions for reference intervals.
View Article and Find Full Text PDFWhich are more correctly diagnosed: conventional Papanicolaou smears or Thinprep samples? A comparative study of 9 years of external quality-assurance testing.
Cancer Cytopathol
February 2015
University of Queensland Center for Clinical Research, The University of Queensland, Herston, Brisbane, Queensland, Australia; Pathology Queensland, The Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia; School of Medicine, The University of Queensland, Herston, Brisbane, Queensland, Australia; The Royal College of Pathologists of Australasia Cytopathology Quality Assurance Program, St. Leonards, Sydney, New South Wales, Australia.
Background: The Royal College of Pathologists of Australasia Cytopathology Quality Assurance Program offers external testing in gynecologic cytology to Australasian and international laboratories. Laboratory interpretation of conventional Papanicolaou (Pap) smears is compared with interpretation of liquid-based cervical cytologic (ThinPrep) samples.
Methods: Conventional Pap smears and ThinPrep samples were distributed to participating laboratories annually over 9 years (from 2004 to 2012), and a range of entities was tested.
Editorial: Pathology in its fortieth year.
Pathology
January 2008
Editor, Pathology, The Royal College of Pathologists of Australasia; Bosch Insitute, Discipline of Pathology and Central Clinical School, University of Sydney.
The impact of the pathology workforce crisis on acute health care.
Aust Health Rev
April 2007
The Royal College of Pathologists of Australasia, 207 Albion Street, Surry Hills, NSW.
There is much talk of the crisis in medical workforce. This paper outlines the huge problem facing pathology services in Australia and the impact this will have on the delivery of health care services.
View Article and Find Full Text PDFExternal quality assurance of molecular analysis of haemochromatosis gene mutations.
J Clin Pathol
July 2006
The Royal College of Pathologists of Australasia Quality Assurance Programs, Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Australia.
Background: The Royal College of Pathologists of Australasia Quality Assurance Programs has conducted an external quality assurance programme for the testing of the haemochromatosis gene (HFE) mutations C282Y and H63D.
Methods: A total of 10 surveys have been undertaken over a period of 6 years from 2000 to 2005.
Results: Of the 3016 responses received, the overall success rate was found to be 99.